GB2090535A - Medical inserts - Google Patents
Medical inserts Download PDFInfo
- Publication number
- GB2090535A GB2090535A GB8200218A GB8200218A GB2090535A GB 2090535 A GB2090535 A GB 2090535A GB 8200218 A GB8200218 A GB 8200218A GB 8200218 A GB8200218 A GB 8200218A GB 2090535 A GB2090535 A GB 2090535A
- Authority
- GB
- United Kingdom
- Prior art keywords
- insert
- water
- insert according
- shape
- ear
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000037431 insertion Effects 0.000 claims abstract description 12
- 238000003780 insertion Methods 0.000 claims abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000011159 matrix material Substances 0.000 claims abstract description 10
- 239000002657 fibrous material Substances 0.000 claims abstract description 9
- 239000008187 granular material Substances 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 7
- 230000008961 swelling Effects 0.000 claims abstract description 6
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 239000000203 mixture Substances 0.000 description 12
- 239000000463 material Substances 0.000 description 10
- 238000001356 surgical procedure Methods 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 description 5
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000440 bentonite Substances 0.000 description 3
- 229910000278 bentonite Inorganic materials 0.000 description 3
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 210000000959 ear middle Anatomy 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 210000001595 mastoid Anatomy 0.000 description 3
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 3
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 3
- 229960002216 methylparaben Drugs 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 229960002152 chlorhexidine acetate Drugs 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 206010033072 otitis externa Diseases 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- PDTFCHSETJBPTR-UHFFFAOYSA-N phenylmercuric nitrate Chemical compound [O-][N+](=O)O[Hg]C1=CC=CC=C1 PDTFCHSETJBPTR-UHFFFAOYSA-N 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 2
- 229940033663 thimerosal Drugs 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229920003043 Cellulose fiber Polymers 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000037237 body shape Effects 0.000 description 1
- ZOMBKNNSYQHRCA-UHFFFAOYSA-J calcium sulfate hemihydrate Chemical compound O.[Ca+2].[Ca+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O ZOMBKNNSYQHRCA-UHFFFAOYSA-J 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003221 ear drop Substances 0.000 description 1
- 229940047652 ear drops Drugs 0.000 description 1
- 210000003027 ear inner Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 1
- 229910000271 hectorite Inorganic materials 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000009838 otomycosis Diseases 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000003454 tympanic membrane Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F11/00—Methods or devices for treatment of the ears or hearing sense; Non-electric hearing aids; Methods or devices for enabling ear patients to achieve auditory perception through physiological senses other than hearing sense; Protective devices for the ears, carried on the body or in the hand
- A61F11/06—Protective devices for the ears
- A61F11/08—Protective devices for the ears internal, e.g. earplugs
- A61F11/10—Protective devices for the ears internal, e.g. earplugs inflatable or expandable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/2022—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/2051—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the material or the structure of the inner absorbing core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/2074—Tampons, e.g. catamenial tampons; Accessories therefor impregnated with hydrophobic, hydrophilic, skin enhancers, medicinal etc. substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/2002—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the use
- A61F13/2005—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the use specially adapted for the nose cavity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Acoustics & Sound (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Otolaryngology (AREA)
- Psychology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Prostheses (AREA)
Abstract
A shaped, hydrophilic, water- swellable medical insert for insertion into a body orifice, which substantially retains its shape on swelling in the presence of water, which comprises a granular or fibrous material dispersed in a matrix, and in which the shape includes a head portion 1 of large cross-section, normal to the axis of insertion (A), relative to a body portion 2. The insert may include a medicament. It may be used to support a graft. <IMAGE>
Description
SPECIFICATION
Medical inserts
This invention relates to bodies which can be used as medical inserts, i.e. as inserts for body orifices such as the auditory meatus.
Ear plugs are known. It is also known to insert a member into the auditory meatus following surgery. A known material for use in such circumstances is natural sponge. Sponge does not expand and, in order to provide a protective cover over, say, a graft, it is necessary to insert an unsatisfactorily large amount of the material into the auditory meatus. This can cause pressure on a graft. Further, a wound may grow into the sponge; this can cause reopening of the wound when the sponge is removed.
Tampons are examples of swellable body inserts. The material of tampons is generally cellular or fibrous throughout. Their shape is generally right cylindrical.
A shaped, hydrophilic, water-swellable material insert according to the present invention, for insertion into a body orifice, comprises a granular or fibrous material dispersed in a matrix; the shape of the body should be substantially retained on swelling in the presence of water; the body shape includes a head portion of relatively large cross-section, normal to the axis of insertion.
Inserts of the invention will now be described by way of example for use in the auditory meatus. In such use, they may be swollen in situ by the introduction of water of an aqueous medication, e.g. comprising antibiotics, or by moisture from a wound in the meatus which it is desired to treat. If it is desired that the material of the insert should grow into a wound in the meatus, it is preferred that the body should be a gel.
Since an insert of the invention maintains its shape on swelling, its use can be controlled to a large extent. It can support a graft, and hold that graft despite coughing. The insert may comprise a medicament and, by suitable choice of materials, this medicament can be allowed to reach a wound or graft in a controlled manner. Example of medicaments which can be used are chlorhexidine acetate, methylparaben, phenylmercuric nitrate, thimerosal and sodium benzoate.
An insert of the invention can be prepared by dehydration of the mixed consistuent materials. Steam pressure may be used in formation although it will often be suitable simply to form the mixture in a suitable mould. The insert may be simply sterilised, e.g. by radiation. It is available for use in a variety of loci including wards, outpatients and theatres.
An insert of the invention is simple to use.
In use, it can expand by up to 30 times its dehydrated size; the degree of swelling can be controlled as desired. The swollen insert can act mechanically to overcome oedema and provide protection, to grafts against coughing and straining constipation, and to the middle ear against infection, by acting as a seal. The insert may comprise suitable components to these ends, including ear drops.
An insert of the invention can be used in assocation with an ear cap. It is particularly suitable for use with the device described in my International Patent Publication No. WO 81/02515.
The fibrous or granular material used in an insert of the invention will generally be at least partially hydrophilic and absorptive. The material may be organic or inorganic, e.g.
hydro-colloidal, and examples are cellulosic materials such as oxidised cellulose, bentonite, colloidal silica, hectorite and laporite.
The matrix used in an insert of the invention will generally also be hydrophilic and absorptive. Suitable materials include polyvinyl alcohol, polyvinyl pyrrolidone, silicones and gelatin, and mixtures of two or more thereof. Gelatin is the most preferred matrix material.
An insert of the invention may consist solely of the granular or fibrous material and matrix material, optionally with a medicament and/ or a disinfectant. Fillers may however also be included, for bulk/stability, which are neither hydrophilic or absorptive. The body will generally comprise at least 50, e.g. 75, % by weight of the granular or fibrous material and any filler, the balance, e.g. 25% by weight, being the matrix material. For use in the auditory meatus, the dehydrated body will usually have a maximum cross-section, i.e.
orthogonal to the axis of insertion, of 6 mm.
Its length, i.e. along the axis of insertion, will generally be at least 10, and usually at least 15, mm, in order that the insert can be easily grasped for removal.
The structure of an insert of the invention will be such that the fibrous or granular material is substantially uniformly distributed in the matrix. Such a structure allows water to be distributed evenly throughout the body, by capillary action; this allows substantially uniform swelling, so that the swollen body retains the shape of the dehydrated body. If the body comprises a fibrous material embedded in a matrix, the fibres may suitably be orientated along the axis of insertion of the body.
In a first embodiment of the invention, a medical insert comprises a body having a generally T-shaped cross-section (in all planes common to the axis of insertion). It is intended that the head of the insert, which may be described as a meato-tympanic ear wick, should come into contact with the tympanic membrane, the "stem" of the body serving as a means to locate the insert in, and remove it from, the ear. The head may have a thickness of about 1 mm and a total width of about 5 mm. The stem may be about 2 mm wide and about 15 mm long, in which case, in use, it will protude from the aditory meatus by, say, 1 to 2 mm.
The T-shaped insert described above may be used for many conditions affecting the external auditory meatus of the human ear.
For example, it may be used to treat traumatic injury to the meatal skin or to the bony cartilaginous skeleton of the meatus, alergic conditions affecting the skin of the meatus, e.g. allergic external otitis with oedema of the skin, all bacterial and viral conditions affecting the meatal skin, e.g. otomycosis, furuncles and herpetic lesions, and otitis externa malignans. Such an insert may also be applied to the human ear following all types of surgery, particularly operations involving repair of defects in the drum head, mastoid surgery of the middle ear, surgery of the inner ear, all forms of tympanoplasty and all kinds of surgery involving the external auditory meatus.
A second embodiment of the invention is broadly similar to the first embodiment described above. However, the T-shape is modified so that one side of the stem, the mastoid side, is convex outwards. In this case, the minimum and maximum thicknesses of the stem may be of the order of 2 and 4 mm, respectively.
This modified T-shape cross-section insert may be described as a meato-mastoid ear wick. It is suitable for all types of tympanoplasty involving mastoid surgery with the drainage point through the external auditory meatus. The "bulge" is designed to fill the surgically created cavity and to support the meato-mastoid skin flap or graft.
A third embodiment of the invention is ovoid in cross-section. In the dehydrated state, such a body, which may be termed an oto-tympanic ear pill, may have a maximum thickness of no more than 2 mm.
A pill-type insert of the type described may be applied to the human ear at the end of any surgical operation to the middle ear or which involves application of a graft or tympanic flap. Such an insert should be applied in order to keep a graft in position, and to support a prosthesis in any type of osiculoplasty, e.g.
incudo-stapedopexy. Such a body can act as a glue, following which an insert, for example of either of the first two types described above, can be inserted, depending on the type of surgery involved.
The invention will now be described by way of example with reference to the accompanying drawings. The three figures respectively show cross-sections of the three embodiments of ear inserts of the invention. The inserts illustrated in Figs. 1 and 2 comprise a head 1 and a stem 2. In all three figures, the intended direction of insertion into the auditory meatus is shown by the arrow at A.
The following Examples illustrate the preparation of inserts of the invention.
Example 1
100 mg chlorhexidine acetate were dissolved in 275 ml distilled water and 500 ml of a 0.08% aqueous mixture of methylparaben and propylparaben (2:1) were added. 50 g polyvinyl alcohol W25/140 were added and dissolved with the aid of heat on a water bath, with continuous stirring. 15 ml triethanolamine were dissolved in 200 ml glycine, and 1 g pectin was added. Following cooling, the glycerine mixture was added to the polyvinyl alcohol/-water mixture, with stirring. Distilled water was added to achieve the desired consistency. The mixture was poured into a ceramic mould tray and allowed to dry, to provide pills as illustrated in Fig. 3.
Example 1 was repeated using Pharmagel instead of pectin, and 1:50000 phenylmercuric nitrate, 1:50000 thimerosal, 1.5% sodium benzoate or a 0.2% methylpareben/-0.02% propylparaben mixture instead of the given paraben mixture. Such pills can be used in post-operative cases where profuse bleeding has occurred.
Example 2
10 g zinc oxide were mixed with 40 g sterilised bentonite and 200 ml glycerine. The mixture was sprinkled onto the surface of hot water, allowed to stand for 24 hours with occasional stirring, and allowed to cool.
10 g polyvinyl alcohol W25/140 were added to 200 ml cold distilled water, and then dissolved over a water bath, with continuous stirring, and allowed to cool. Separately, 2 g zinc oxide, 500 mg dried calcium sulphate, 30 ml glycerine and 0.08% methylparaben were mixed together, and subsequently with a mixture of the cooled polyvinyl alcohol solution and bentonite-containing system.
Cellulose fibres were prepared by dissolving wood pulp or short fibre cotton in caustic soda and carbon disulphide, and forcing the solution through spinnerets into an acid salt bath. The mixture obtained above was spread on a ceramic mould and the fibres were implanted. The mixture was then moulded as desired, e.g. as illustrated in Fig. 1.
Claims (6)
1. A shaped, hydrophilic, water-swellable medical insert, for insertion into a body orifice, which substantially retains its shape on swelling in the presence of water, which comprises a granular or fibrous material dispersed in a matrix, and in which the shape includes a head portion of relatively large cross-section, normal to the axis of insertion.
2. An insert according to claim 1, which includes a medicament.
3. An insert according to claim 1 or claim 2, which has a maximum cross-section, normal to the axis of insertion, of 6 mm.
4. An insert according to any preceding claim, in which the fibrous or granular material is at least partially hydrophilic and absorptive.
5. An insert according to any preceding claim, in which the matrix comprises gelatin.
6. A graft supported on an insert according to any preceding claim.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8200218A GB2090535B (en) | 1981-01-06 | 1982-01-05 | Medical inserts |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8100254 | 1981-01-06 | ||
| GB8200218A GB2090535B (en) | 1981-01-06 | 1982-01-05 | Medical inserts |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GB2090535A true GB2090535A (en) | 1982-07-14 |
| GB2090535B GB2090535B (en) | 1984-09-19 |
Family
ID=26278032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8200218A Expired GB2090535B (en) | 1981-01-06 | 1982-01-05 | Medical inserts |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2090535B (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2139898A (en) * | 1983-05-09 | 1984-11-21 | Donald James Highgate | Deformable polymeric compositions |
| GB2215207A (en) * | 1988-01-28 | 1989-09-20 | Fulmer Yarsley Ltd | Sustained release pharmaceutical dosage units |
| GB2176105B (en) * | 1985-06-04 | 1990-03-07 | Sandoz Ltd | Nasal inserts dispensing pharmaceuticals. |
| DE9200765U1 (en) * | 1991-01-23 | 1992-04-16 | British Technology Group plc, London | Composition for controlled drug release |
| US5131411A (en) * | 1990-08-20 | 1992-07-21 | Virginia Polytechnic Institute & State University | Custom-fitting earplug formed in situ using foaming action |
| WO1997036642A1 (en) * | 1996-03-29 | 1997-10-09 | Iotek, Inc. | Fiber matrix and device for treating urogenital disorders |
| WO1997036641A1 (en) * | 1996-03-29 | 1997-10-09 | Iotek, Inc. | Vaginal insert and device for treating urogenital disorders |
| WO1997036643A1 (en) * | 1996-03-29 | 1997-10-09 | Iotek, Inc. | Compressible vaginal insert and device for treating urogenital disorders |
| WO1997036644A1 (en) * | 1996-03-29 | 1997-10-09 | Iotek, Inc. | Channeled vaginal insert and device for treating urogenital disorders |
| WO1999017837A1 (en) * | 1997-10-06 | 1999-04-15 | Iotek, Inc. | Iontophoretic agent delivery to the female reproductive tract |
-
1982
- 1982-01-05 GB GB8200218A patent/GB2090535B/en not_active Expired
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2139898A (en) * | 1983-05-09 | 1984-11-21 | Donald James Highgate | Deformable polymeric compositions |
| GB2176105B (en) * | 1985-06-04 | 1990-03-07 | Sandoz Ltd | Nasal inserts dispensing pharmaceuticals. |
| GB2215207A (en) * | 1988-01-28 | 1989-09-20 | Fulmer Yarsley Ltd | Sustained release pharmaceutical dosage units |
| US5131411A (en) * | 1990-08-20 | 1992-07-21 | Virginia Polytechnic Institute & State University | Custom-fitting earplug formed in situ using foaming action |
| DE9200765U1 (en) * | 1991-01-23 | 1992-04-16 | British Technology Group plc, London | Composition for controlled drug release |
| WO1997036642A1 (en) * | 1996-03-29 | 1997-10-09 | Iotek, Inc. | Fiber matrix and device for treating urogenital disorders |
| WO1997036641A1 (en) * | 1996-03-29 | 1997-10-09 | Iotek, Inc. | Vaginal insert and device for treating urogenital disorders |
| WO1997036643A1 (en) * | 1996-03-29 | 1997-10-09 | Iotek, Inc. | Compressible vaginal insert and device for treating urogenital disorders |
| WO1997036644A1 (en) * | 1996-03-29 | 1997-10-09 | Iotek, Inc. | Channeled vaginal insert and device for treating urogenital disorders |
| US5988169A (en) * | 1996-03-29 | 1999-11-23 | Iotek, Inc. | Vaginal insert and method for treating urogenital disorders |
| WO1999017837A1 (en) * | 1997-10-06 | 1999-04-15 | Iotek, Inc. | Iontophoretic agent delivery to the female reproductive tract |
| US6139538A (en) * | 1997-10-06 | 2000-10-31 | Iotek, Inc. | Iontophoretic agent delivery to the female reproductive tract |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2090535B (en) | 1984-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69032125T2 (en) | GEL Wound Dressing Compositions And Method For Using Them | |
| CA1092023A (en) | Intravaginal contraceptive and drug release device and method for making and using same | |
| AU2007221150B2 (en) | Eustachian tube device and method | |
| DE69014614T2 (en) | Delayed release wound dressing formulations and their use. | |
| US6316598B1 (en) | Water absorbent keratin and gel formed therefrom | |
| RU2544367C2 (en) | Agent for ear-drum or external auditory canal restoration | |
| DE69616514T2 (en) | ORGANIC EDIBLE OPHTALMIC SIGN | |
| GB2090535A (en) | Medical inserts | |
| Shen et al. | To pack or not to pack? A contemporary review of middle ear packing agents | |
| US4274410A (en) | Intravaginal contraceptive and drug release device and method for making and using same | |
| Laurent et al. | Repair of chronic tympanic membrane perforations using applications of hyaluronan or rice paper prostheses | |
| Hartwein et al. | The total reconstruction of the tympanic membrane by the “crowncork” technique | |
| Jahnke et al. | Bioinert ceramic implants in middle ear surgery | |
| US4692143A (en) | Unit package containing ready-to-use vaginal contraceptive | |
| JP2002104974A (en) | Hydrogel therapeutic agent for damaged skin | |
| Adkins et al. | Use of a composite autograft to prevent recurrent cholesteatoma caused by canal wall defects | |
| Frerichs et al. | One-stage endaural musculotympanoplasty | |
| Proud et al. | Mastoidectomy and epitympanotomy | |
| Goodhill | LXXII Deliberate “Spontaneous” Tympanoplasty: Roles of Annular Induction and Basement Membranes | |
| Steinbach et al. | Cholesteatoma—pathology and treatment | |
| Wolferman | Twenty-five years of tympanoplasty: a critical evaluation | |
| Smith | Management of the draining open mastoid cavity | |
| Hambley et al. | Failure of proplast in mastoid obliteration | |
| ES2343606T3 (en) | MATRIX OF ACTIVE SUBSTANCES IN THE FORM OF A BIOREABSORBABLE POROUS VELLON ELABORATED FROM COLAGEN FIBRILLES, PROCEDURE FOR MANUFACTURING AND USE. | |
| Brandow | Homograft tympanic membrane myringoplasty |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PCNP | Patent ceased through non-payment of renewal fee |